Latest Balance Sheet News

Brockman Mining has regained full control of its Ophthalmia Project after Polaris Metals surrendered its joint venture interest, ending a loan obligation and opening new development options.

Medallion Metals has raised A$60 million through a targeted placement, boosting its liquidity to about A$175 million and enabling accelerated development of its Ravensthorpe Gold Project and drilling programs in Western Australia.

Pacific Edge’s draft Medicare Local Coverage Determination for its Cxbladder bladder cancer tests marks a pivotal step toward unlocking a $10.2 billion global market. Despite FY26 setbacks, the company is poised for growth with improved reimbursement prospects and strategic cost management.

IDT Australia reports a sharp turnaround in FY26 with a 66% reduction in net loss and an 85% improvement in EBITDA, underpinned by a strategic reset and targeted investments in manufacturing capabilities.

Perpetual Equity Investment Company (ASX: PIC) posted a 44.4% drop in net profit to $12.1 million for FY26, yet held its fully franked dividend steady at 8.0 cents per share and announced a shift to monthly dividend payments starting December 2026.

Vicinity Centres delivered a robust FY26 with a $1.39 billion statutory net profit, strategic acquisitions in key growth corridors, and a strengthened premium retail portfolio.

Motio Ltd (ASX:MXO) reported a solid FY26 with revenue rising to $9.2 million, a 31% jump in cash EBITDA to $2.5 million, and a net profit before tax of $1.7 million. The company enters FY27 debt free and with forward revenue up 28%, signalling operational leverage and growth potential.

Zuleika Gold recommends shareholders accept CZR Resources’ off-market takeover offer, which values Zuleika’s mineral assets at a preferred $6.1 million. The independent expert deems the offer not fair but reasonable.

Dimerix has received a US$10 million upfront payment from Everest Medicines under a regional licensing deal for DMX-200 targeting FSGS in Greater China, South Korea and Southeast Asia. This deal marks Dimerix’s fifth commercial partnership for DMX-200, collectively worth up to A$1.9 billion in milestones and royalties.

Codan Limited posted a robust FY26 with revenue up 30% to $875 million and net profit soaring 69% to $175 million, underpinned by strong demand in communications and metal detection segments. The company declared a fully franked final dividend of 29 cents, lifting the full-year payout by 70%.

Noumi Limited lifted FY26 revenue by 8.8% and adjusted operating EBITDA by 7.6%, driven by Dairy & Nutritionals' strong earnings and strategic investments in Plant-based Milks. The company faces refinancing uncertainty with $610 million convertible notes maturing in May 2027, prompting a proposed acquisition by majority shareholder Arrovest.

Medical Developments International (ASX:MVP) reported a 9% revenue increase to $42.6 million and a 566% jump in net profit to $0.6 million for FY26, driven by robust growth in its Pain Management segment and expanded paediatric approvals in Europe.